Private company agreed to note, with options to purchase at 5.76, putting the value after dilution at 5.76 with a market cap well above current levels 570+ million. A buyout may still be in works, but this was actually a good deal done by the company at current levels.
sgen will be $32-$37 for the next 8 months. imgn will be $20 post april and longer term is better for those that get in now for imgn.
all fine when the company gets sold. "Outperform” Rating from Oppenheimer
the doctor told me HL was a good investment. looks like this doctor is a bit slow...
Protalix Biotherapeutics attractive as long term holding – and takeover target